RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome
- 1 June 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (11) , 2325-2339
Abstract
The recurring association of specific genetic lesions with particular types of cancer is a fascinating and largely unexplained area of cancer biology. This is particularly true of clear cell renal cell carcinoma (ccRCC) where, although key mutations such as loss of VHL is an almost ubiquitous finding, there remains a conspicuous lack of targetable genetic drivers. In this study, we have identified a previously unknown protumorigenic role for the RUNX genes in this disease setting. Analysis of patient tumor biopsies together with loss-of-function studies in preclinical models established the importance of RUNX1 and RUNX2 in ccRCC. Patients with high RUNX1 (and RUNX2) expression exhibited significantly poorer clinical survival compared with patients with low expression. This was functionally relevant, as deletion of RUNX1 in ccRCC cell lines reduced tumor cell growth and viability in vitro and in vivo. Transcriptional profiling of RUNX1-CRISPR–deleted cells revealed a gene signature dominated by extracellular matrix remodeling, notably affecting STMN3, SERPINH1, and EPHRIN signaling. Finally, RUNX1 deletion in a genetic mouse model of kidney cancer improved overall survival and reduced tumor cell proliferation. In summary, these data attest to the validity of targeting a RUNX1-transcriptional program in ccRCC.Significance: These data reveal a novel unexplored oncogenic role for RUNX genes in kidney cancer and indicate that targeting the effects of RUNX transcriptional activity could be relevant for clinical intervention in ccRCC.Keywords
All Related Versions
Funding Information
- Cancer Research UK (C596/A17196)
- CRUK (C596/A17196)
This publication has 64 references indexed in Scilit:
- Whole-genome analysis informs breast cancer response to aromatase inhibitionNature, 2012
- Runx2 Protein Stabilizes Hypoxia-inducible Factor-1α through Competition with von Hippel-Lindau Protein (pVHL) and Stimulates Angiogenesis in Growth Plate Hypertrophic ChondrocytesJournal of Biological Chemistry, 2012
- Physical and functional interactions between Runx2 and HIF-1α induce vascular endothelial growth factor gene expressionJournal of Cellular Biochemistry, 2011
- Modernizing Reference Genome AssembliesPLOS Biology, 2011
- A Rapid and Simple Procedure for the Establishment of Human Normal and Cancer Renal Primary Cell Cultures from Surgical SpecimensPLOS ONE, 2011
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaNature, 2011
- A scalable, fully automated process for construction of sequence-ready human exome targeted capture librariesGenome Biology, 2011
- p21 loss blocks senescence following Apc loss and provokes tumourigenesis in the renal but not the intestinal epitheliumEMBO Molecular Medicine, 2010
- Runx1 Directly Promotes Proliferation of Hair Follicle Stem Cells and Epithelial Tumor Formation in Mouse SkinMolecular and Cellular Biology, 2010
- Runx Expression Is Mitogenic and Mutually Linked to Wnt Activity in Blastula-Stage Sea Urchin EmbryosPLOS ONE, 2008